| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |